as on January 17, 2026 at 2:29 am IST
Day's Low
Day's High
1.31%
Downside
6.11%
Upside
52 Week's Low
52 Week's High
31.00%
Downside
934.93%
Upside
Check Dermata Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.0M
EPS (TTM)
-8
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.14
Industry PE ratio
0PEG Ratio
0EBITDA
-7.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-203.36%
Track how Dermata Therapeutics Inc P/E has moved over time to understand its valuation trends.
Dermata Therapeutics Inc in the last 5 years
Lowest (-99.25x)
March 31, 2022
Industry (0.00x)
January 16, 2026
Today (0.14x)
January 16, 2026
Highest (-0.30x)
June 30, 2025
Today’s Price to Earnings Ratio: 0.14x
Compare market cap, revenue, PE, and other key metrics of Dermata Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $7.0M | NA | 0.14 | 0.00% | |
| BUY | $47.5B | 115.95% | 1238.83 | 1.36% | |
| BUY | $112.5B | 94.6% | 30.87 | 31.35% | |
| NA | $37.4B | NA | 663.31 | 1.38% | |
| BUY | $78.6B | 43.25% | 17.79 | 32.13% |
The Dermata Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dermata Therapeutics Inc investment value today
Current value as on today
₹22,104
Returns
Returns from Dermata Therapeutics Inc Stock
Dollar Returns*
₹4,886 (+4.89%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Dermata Therapeutics Inc. Average target price of $10
Get share price movements and forecasts by analysts on Dermata Therapeutics Inc.
What analysts predicted
77.1%UPSIDE
Target Price
$10
Current Price
$2.29
Analyzed by
7 Analysts
Target
$10.00
Dermata Therapeutics Inc target price $10, a slight upside of 77.1% compared to current price of $2.29. According to 7 analysts rating.
Search interest for Dermata Therapeutics Inc Stock has increased by 878% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:878% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 30 December
Tue, 11:24 AM
-Dermata Therapeutics closes $12.4 million private placement, shares rise 10.2% in after-hours trading.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, DRMA stock has moved up by 8.2%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.0% return, outperforming this stock by 124.7%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 64.7% return, outperforming this stock by 147.8%
| Organisation | Dermata Therapeutics Inc |
| Headquarters | 3525 Del Mar Heights Rd., San Diego, CA, United States, 92130 |
| CEO | Mr. Gerald T. Proehl |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Gerald T. Proehl | Founder, President, CEO & Chairman |
Mr. David F. Hale | Co-Founder & Lead Independent Director |
Ms. Kyri K. Van Hoose CPA, M.B.A. | Senior VP & CFO |
Dr. Christopher J. Nardo M.P.H., Ph.D. | Senior VP & Chief Development Officer |
Mr. Sean Proehl | Associate General Counsel |
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D. | Senior Vice President of Regulatory Affairs & Quality Assurance |
Dermata Therapeutics Inc share price today is $2.29 as on at the close of the market. Dermata Therapeutics Inc share today touched a day high of $2.43 and a low of $2.26.
Dermata Therapeutics Inc share touched a 52 week high of $23.7 on and a 52 week low of $1.58 on . Dermata Therapeutics Inc stock price today i.e. is closed at $2.29,which is 90.34% down from its 52 week high and 44.94% up from its 52 week low.
Dermata Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Dermata Therapeutics Inc (DRMA) shares with as little as ₹90.81 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.10 in Dermata Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dermata Therapeutics Inc share’s latest price of $2.29 as on January 17, 2026 at 2:29 am IST, you will get 4.3668 shares of Dermata Therapeutics Inc. Learn more about
fractional shares .